Guobing Yin

667 total citations
39 papers, 469 citations indexed

About

Guobing Yin is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cancer Research. According to data from OpenAlex, Guobing Yin has authored 39 papers receiving a total of 469 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Surgery and 10 papers in Cancer Research. Recurrent topics in Guobing Yin's work include Thyroid Cancer Diagnosis and Treatment (9 papers), Thyroid and Parathyroid Surgery (6 papers) and Breast Cancer Treatment Studies (6 papers). Guobing Yin is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (9 papers), Thyroid and Parathyroid Surgery (6 papers) and Breast Cancer Treatment Studies (6 papers). Guobing Yin collaborates with scholars based in China, Japan and Hong Kong. Guobing Yin's co-authors include Yu Min, Yang Feng, Xing Wang, Hang Chen, Haojun Luo, Le Yu, Zhenghong Lin, Daixing Hu, George Y. Chen and Ni Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Molecular and Cellular Biology and Frontiers in Immunology.

In The Last Decade

Guobing Yin

36 papers receiving 466 citations

Peers

Guobing Yin
Andreas Giannakou United States
Abderrahman Ouban Saudi Arabia
Xingyun Su China
Katsuya Matsuda Japan
Ting‐Chun Kuo Taiwan
Tania Pilli Italy
Jean‐Nicolas Gallant United States
Gwendolyn Vliegen Belgium
Jung Hyun Yang South Korea
Xiaoyin Tang China
Andreas Giannakou United States
Guobing Yin
Citations per year, relative to Guobing Yin Guobing Yin (= 1×) peers Andreas Giannakou

Countries citing papers authored by Guobing Yin

Since Specialization
Citations

This map shows the geographic impact of Guobing Yin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guobing Yin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guobing Yin more than expected).

Fields of papers citing papers by Guobing Yin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guobing Yin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guobing Yin. The network helps show where Guobing Yin may publish in the future.

Co-authorship network of co-authors of Guobing Yin

This figure shows the co-authorship network connecting the top 25 collaborators of Guobing Yin. A scholar is included among the top collaborators of Guobing Yin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guobing Yin. Guobing Yin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Hongyuan, et al.. (2024). Therapeutic advances in hepatocellular carcinoma: an update from the 2024 ASCO annual meeting. Frontiers in Oncology. 14. 1453412–1453412. 9 indexed citations
2.
Li, Zhi, Cheng Chen, Zhiping Peng, et al.. (2024). Application of fluorocarbon nanoparticles of 131I-fulvestrant as a targeted radiation drug for endocrine therapy on human breast cancer. Journal of Nanobiotechnology. 22(1). 107–107. 3 indexed citations
3.
Min, Yu, Hang Chen, Jiaxin Yang, et al.. (2023). A multi-dimensional nomogram to predict non-sentinel lymph node metastases in T1–2HR+ breast cancer. Frontiers in Endocrinology. 14. 1121394–1121394. 3 indexed citations
4.
Yang, Jiaxin, Yu Min, Cheng Chen, et al.. (2023). Prophylactic central neck dissection for cN0 papillary thyroid carcinoma: is there any difference between western countries and China? A systematic review and meta-analysis. Frontiers in Endocrinology. 14. 1176512–1176512. 6 indexed citations
5.
Huang, Yizhou, et al.. (2022). Construction and Validation of a Prediction Model for Identifying Clinical Risk Factors of Lateral Lymph Node Metastasis in Medullary Thyroid Carcinoma. SHILAP Revista de lepidopterología. 3 indexed citations
6.
7.
Liu, Rui, Daixing Hu, Haojun Luo, et al.. (2022). Cancer-Specific Survival Outcome in Early-Stage Young Breast Cancer: Evidence From the SEER Database Analysis. Frontiers in Endocrinology. 12. 811878–811878. 14 indexed citations
8.
Han, Yuling, et al.. (2022). Safety and Immunogenicity of Inactivated and Recombinant Protein SARS-CoV-2 Vaccines in Patients With Thyroid Cancer. Frontiers in Immunology. 13. 855311–855311. 2 indexed citations
9.
Min, Yu, Yang Feng, Yijie Huang, et al.. (2021). Development and validation of an individualized nomogram for predicting the high-volume (> 5) central lymph node metastasis in papillary thyroid microcarcinoma. Journal of Endocrinological Investigation. 45(3). 507–515. 21 indexed citations
10.
Min, Yu, Xiaoman Liu, Daixing Hu, et al.. (2021). Risk Factors, Prognostic Factors, and Nomogram for Distant Metastasis in Breast Cancer Patients Without Lymph Node Metastasis. Frontiers in Endocrinology. 12. 771226–771226. 17 indexed citations
11.
Chang, Liisa, Chuanhua Zhao, Ru Jia, et al.. (2021). Peripheral blood T-cell receptor repertoire as a predictor of clinical outcomes in gastrointestinal cancer patients treated with PD-1 inhibitor. Clinical & Translational Oncology. 23(8). 1646–1656. 13 indexed citations
12.
Feng, Yang, et al.. (2021). Construction and validation of a nomogram for predicting cervical lymph node metastasis in classic papillary thyroid carcinoma. Journal of Endocrinological Investigation. 44(10). 2203–2211. 38 indexed citations
13.
Wang, Xing, et al.. (2021). Prostaglandin Reductase 1 as a Potential Therapeutic Target for Cancer Therapy. Frontiers in Pharmacology. 12. 717730–717730. 23 indexed citations
14.
15.
Yin, Guobing, et al.. (2020). KLHL5 Is a Prognostic-Related Biomarker and Correlated With Immune Infiltrates in Gastric Cancer. Frontiers in Molecular Biosciences. 7. 599110–599110. 5 indexed citations
16.
Min, Yu, et al.. (2020). Thermal Ablation for Papillary Thyroid Microcarcinoma: How Far We Have Come?. Cancer Management and Research. Volume 12. 13369–13379. 32 indexed citations
17.
Yin, Guobing, et al.. (2014). Coexistence of Fabry disease and IgA nephropathy: a report of two cases. Irish Journal of Medical Science (1971 -). 183(4). 671–675. 5 indexed citations
18.
Wang, Ni, Haojun Luo, Guobing Yin, et al.. (2013). Overexpression of HIF-2α, TWIST, and CXCR4 Is Associated with Lymph Node Metastasis in Papillary Thyroid Carcinoma. SHILAP Revista de lepidopterología. 2013. 1–9. 39 indexed citations
19.
Yin, Guobing. (2006). Expression and influencing factors of CD54 in Hashimotos thyroiditis. Di-san junyi daxue xuebao. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andreas Giannakou Breakdown of academic impact, for papers by Abderrahman Ouban Breakdown of academic impact, for papers by Xingyun Su Breakdown of academic impact, for papers by Katsuya Matsuda Breakdown of academic impact, for papers by Ting‐Chun Kuo Breakdown of academic impact, for papers by Tania Pilli Breakdown of academic impact, for papers by Jean‐Nicolas Gallant Breakdown of academic impact, for papers by Gwendolyn Vliegen Breakdown of academic impact, for papers by Jung Hyun Yang Breakdown of academic impact, for papers by Xiaoyin Tang
Rankless by CCL
2026